205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.66%
Net income growth at 75-90% of ADI's 12.78%. Bill Ackman would call for strategic or operational tweaks to match competitor’s earnings growth.
6.25%
D&A growth well above ADI's 2.59%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-429.63%
Negative yoy deferred tax while ADI stands at 182.10%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
19.31%
Less working capital growth vs. ADI's 94.25%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
917.24%
AR growth of 917.24% while ADI is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-37.88%
Negative yoy inventory while ADI is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-59.76%
Negative yoy usage while ADI is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-633.33%
Both negative yoy, with ADI at -92.52%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-6.68%
Negative yoy CFO while ADI is 22.01%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
23.99%
CapEx growth well above ADI's 3.48%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-137.29%
Negative yoy acquisition while ADI stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-16.25%
Both yoy lines negative, with ADI at -46.62%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
12.63%
We have some liquidation growth while ADI is negative at -21.66%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
17.22%
Investing outflow well above ADI's 19.10%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
600.00%
Issuance growth of 600.00% while ADI is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.